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ABSTRACT
Candidaemia carries high morbidity and mortality, but its conventional diagnosis is time consuming and insensitive. 
Clinical risk factors may identify suitable candidates for prophylactic or pre-emptive antifungal therapy and may be 
modified or controlled to prevent candidaemia. Therefore, this study aimed to identify the independent risk factors for 
candidaemia. The study was a retrospective, case-control study involving 54 patients with candidaemia and 54 patients 
without candidaemia as controls. The patient’s data were collected from the medical records and the risk factors for 
candidaemia were analyzed in both groups. Candida species isolated from blood were C. tropicalis (n=19, 35.2%), C. 
albicans (n=18, 33.3%), C. parapsilosis (n=11, 20.4%) and one isolate each (1.9%) of C. famata, C. glabrata, C. krusei, C. 
melibiosica, C. pelliculosa and C. sake. Multivariate analysis showed that renal insufficiency, prior antibacterial therapy, 
prior antifungal therapy, steroid therapy and urinary catheterization were independent risk factors for candidaemia. 
Central venous catheter, prolonged hospital stay, intensive care unit stay, mechanical ventilation, surgery and parenteral 
nutrition occurred more commonly among the candidaemia group but were not independently significant. Controlling, 
limiting or modifying these risk factors may reduce the incidence of candidaemia. 
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ABSTRAK
Kandidemia membawa kadar morbiditi dan kematian yang tinggi, namun kaedah diagnosis biasa memakan masa dan 
tidak sensitif. Faktor risiko klinikal boleh mengenal pasti calon sesuai untuk rawatan antikulat profilaktik atau pra-emptif 
dan boleh diubah atau dikawal bagi mencegah kandidemia. Oleh itu, kajian ini menyasarkan untuk mengenal pasti 
faktor risiko bebas untuk kandidemia. Kajian ini merupakan kajian kawalan kes retrospektif yang melibatkan 54 pesakit 
kandidemia dan 54 pesakit tanpa kandidemia sebagai kawalan. Data pesakit diperoleh daripada rekod perubatan dan 
faktor risiko dianalisis dalam kedua-dua kumpulan. Spesies candida yang dipencil daripada darah adalah C. tropicalis 
(n=19, 35.2%), C. albicans (n=18, 33.3%), C. parapsilosis (n=11, 20.4%) dan satu pencilan setiap satu (1.9%) dari 
C. famata, C. glabrata, C. krusei, C. melibiosica, C. pelliculosa dan C. sake. Analisis multivariat menunjukkan bahawa 
kerosakan ginjal, rawatan antibiotik terdahulu, rawatan antikulat terdahulu, rawatan steroid dan pengkateteran urin 
adalah merupakan faktor risiko bebas untuk mendapat kandidemia. Manakala kateter vena utama, inapan hospital 
berpanjangan, inapan unit kawalan intensif, pengalihudaraan mekanik, pembedahan dan nutrisi parenteral berlaku 
lebih kerap dalam kalangan pesakit kandidemia tetapi tidak signifikan. Mengawal, menghad atau mengubah faktor 
risiko ini boleh mengurangkan insiden kandidemia. 
Kata kunci: Faktor risiko; jangkitan darah;  candida; kandidemia
INTRODUCTION
Candidaemia remains the most frequent life-threatening 
fungal disease and is associated with excess mortality, a 
prolonged hospital stay and a resulting rise in costs (Morgan 
et al. 2005). In order to effectively manage these patients, 
clinicians must recognize the risk factors associated with 
candidaemia and identify patients at increased risk, so that 
effective treatment can be offered and also for avoiding 
inappropriate administration of costly and toxic antifungal 
therapy (Patterson et al. 2006). The gold standard for 
the diagnosis of candidaemia is a positive blood culture; 
which should be obtained in all patients with suspected 
candidaemia. However, blood cultures are insensitive 
and serological methods, although more sensitive, are 
not widely used. Clinical risk factors may provide an 
early warning system to clinicians in identifying patients 
at risk so prophylaxis or pre-emptive antifungal therapy 
can be initiated. The risk factors may also be avoided, 
controlled or modified to prevent further occurrences 
of candidaemia in the future. Host-related risk factors 
refer to the underlying diseases of the patient, whereas 
treatment-related risk factors refer to instrumentation or 
medication given to the patient. Therefore this study aimed 
to determine the independent host-related and treatment-
related risk factors for candidaemia.
MATERIALS AND METHODS
The study was a retrospective, unmatched 1:1 case-control 
study of all candidaemia cases in Universiti Kebangsaan 
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Malaysia Medical Centre (UKMMC) from 1st June 2008 
to 31st December 2009. UKMMC is an 850-bedded, 
multidisciplinary tertiary level teaching hospital in Kuala 
Lumpur. A case of candidaemia was defined as a patient 
with at least one positive blood culture for Candida species. 
A control was defined as a patient who was admitted to 
the same ward with the case patient and had a positive 
blood culture but other than fungi. Cases or controls 
who were admitted within 48 h prior to the positive 
blood cultures and whose medical records were missing 
or incomplete were excluded from the study. Repeated 
episodes of candidaemia caused by the same species in 
the same patient within three months period were regarded 
as recurrent infection and were also excluded from the 
study. Data collected from the medical records included 
demography of cases and controls, types of Candida 
species isolated and the presence or absence of potential 
risk factors. The followings were only considered as 
potential risk factors if certain conditions were fulfilled 
in relation to the first episode of candidaemia: Diabetes 
mellitus, human immunodeficiency virus (HIV) infection, 
malignancy and renal insufficiency-if diagnosed at least 
1 month before candidaemia; any major surgery requiring 
general anaesthesia, organ transplantation and parenteral 
nutrition - if done within 2 weeks before candidaemia; 
steroid therapy of a dose equivalent to at least 20 mg/
day prednisolone given for more than 7 days within 
4 weeks before candidaemia; systemic antibacterial, 
systemic antifungal and chemotherapy - if given within 2 
weeks before candidaemia; prolonged hospital stay was 
defined as hospital admission of more than 3 days before 
candidaemia; intensive care unit (ICU) stay was defined 
as ICU admission of more than 48 h before candidaemia; 
central venous catheter, urinary catheter and mechanical 
ventilation - if started at least 48 h before candidaemia; 
haemodialysis was defined as regular haemodialysis 
(usually three times a week); neutropaenia was defined 
as neutrophil counts of less than 500 cells/mm3 and 
prematurity - a neonate who was born before 37 weeks of 
gestation and subsequently had candidaemia while in the 
hospital, within 28 days of life. Alcohol intake and cigarette 
smoking statuses of the study population were also noted. 
Statistical analysis of data was performed with Statistical 
Package for Social Sciences, using chi-square test for 
association between variables. A p-value of <0.05 was used 
to indicate statistically significant differences between the 
groups, and multivariate logistic regression was performed 
to detect independent risk factors. The study was approved 
by the Universiti Kebangsaan Malaysia Medical Research 
and Ethics Committee (UKM 1.5.3.5/244/SPP3).
RESULTS
A total of 54 candidaemia patients and 54 control subjects 
were enrolled during this study period. Men outnumbered 
women in the study population, with 65 (60.2%) men 
and 43 (39.8%) women (ratio 1.5:1). The race and age 
distributions between the candidaemia and control groups 
were not significantly different (Table 1). The majority 
of candidaemia cases came from the general ICU (n=17, 
31.5%), followed by haematology wards (n=9, 16.7%), 
general medical wards (n=7, 13.0%) and surgical wards 
(n=6, 11.1%). Three cases each (5.6%) from nephrology 
and general paediatrics wards; two cases each (3.7%) 
from paediatric ICU, high dependency ward and bone 
marrow transplant unit and one case each (1.9%) from the 
neonatal ICU, orthopaedics ward and burn unit. Candida 
species isolated in this study were C. tropicalis (n=19, 
35.2%), C. albicans (n=18, 33.3%), C. parapsilosis 
(n=11, 20.4%) and one isolate each (1.9%) of C. famata, 
C. glabrata, C. krusei, C. melibiosica, C. pelliculosa 
and C. sake. Bivariate analysis showed that there were 
eleven significant risk factors out of 21 with p values less 
than 0.05, which included renal insufficiency, surgery, 
antibacterial therapy, antifungal therapy, central venous 
catheter, hospital stay, ICU stay, mechanical ventilation, 
TABLE 1. Demographic data of study population
Characteristics Candidaemia 
n=54 (%)
Control 
n=54 (%)
p-value
Sex
 Male
  Female
30 (55.6)
24 (44.4)
35 (64.8)
19 (35.2)
0.326
Race 
  Malay
  Chinese
  Indian
  Others
29 (53.7)
14 (25.9)
5 (9.3)
6 (11.1)
38 (70.4)
12 (22.2)
3 (5.6)
1 (1.9)
0.143
Ages in years (n = 54)
  0 – 9 (children)
  10 – 19 (adolescent)
  20 – 50 (young adults)
  50 –100 (senior adults)
  Mean age
6 (11.1)
2 (3.7)
17 (31.5)
29 (53.7)
45.13 ± 6.08
5 (9.2)
6 (11.1)
14 (26.0)
29 (53.7)
45.28 ± 6.33
0.497
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parenteral nutrition, steroid therapy and urinary catheter 
(Table 2). However, in the final study model, the risk 
factors identified by multiple logistic regression analysis 
used to obtain estimates of risk after simultaneous control 
for other variables, only renal insufficiency, antibacterial 
therapy, antifungal therapy, steroid therapy and urinary 
catheter were significant predictors of candidaemia with 
p-values less than 0.05 (Table 3). From this study model 
summary, the variability explained by the predictors in the 
model is 74%. We can conclude that this study provide 
good predictors for candidaemia cases (Table 4).
DISCUSSION
The gold standard for diagnosing candidaemia is still 
using blood culture, which is slow and insensitive; while 
serological and new methods such as matrix-assisted laser 
desorption ionization-time of flight mass spectrometry 
(MALDI-TOF MS), peptide nucleic acid fluorescent in situ 
hybridization (PNA-FISH) and T2 magnetic resonance 
methods offer a more rapid diagnosis but are not widely 
used (Vitale & Nucci 2014). The recognition of a set 
of easily identifiable independent predictors for the 
occurrence of candidaemia in hospitalized patients will 
provide a rationale for implementing preventive measures 
and initiating antifungal prophylaxis in patients at risk even 
when the patient is not in an obvious immunocompromised 
state. When two or more of these risk factors are present, 
the probability of infection increases exponentially (Pfaller 
& Diekema 2007). This study showed that patients from all 
age groups were affected by candidaemia with the mean 
age of 45.13 years. The senior adults were more frequently 
affected (53.7%), probably because they were more likely 
to have debilitating underlying medical conditions and 
other predisposing factors than younger patients. The 
seemingly high number of candidaemia cases among 
Malays turned out to be not significant. It merely reflected 
the racial distribution of the general Malaysian population. 
The distribution of Candida species isolated in this study 
showed a slightly different pattern when compared with 
a previous study done at the same centre in 2005 to 2006. 
In this study, C. tropicalis (35.2%) formed the majority, 
followed by C. albicans (33.3%) and C. parapsilosis 
(20.4%); whereas the previous study reported the same 3 
major species, but in a different order: C. albicans (40%), 
C. tropicalis (32%) and C. parapsilosis (10%) (Tzar et al. 
2009). In this study, non albicans Candida (NAC) species 
constituted 66.6% of all yeast isolates. This is similar to 
reports from the United Kingdom (Krcmery & Barnes 
2002) which showed 65% of candidaemia cases caused 
by NAC. In their study, 20 to 40% of isolates was C. 
parapsilosis followed by C. tropicalis (10-30%), C. krusei 
and C. glabrata. In contrast, a study by Cheng et al. (2006) 
showed that C. albicans remains the most common isolate 
with 64.8% of the total isolates. 
 In this study, at the onset of candidaemia, all 
patients had at least two risk factors and the most 
common risk factor in this study was previous antibiotic 
TABLE 2. Bivariate analysis of risk factors between candidaemia and control groups
Risk Factors Candidaemia
 (n=54)
Control 
(n=54)
p-value Odds ratio 
(OR)
RR 
(OR with 95% CI)
Host-related factors
 Alcohol
 Diabetes mellitus
 HIV infection
 Malignancy
 Neutropenia 
 Prematurity
 Renal insufficiency
 Smoking
13
25
1
18
17
4
28
20
10
18
1
15
10
1
13
23
0.481
0.169
1.000
0.531
0.120
0.169
0.003*
0.555
1.4
1.7
1.0
1.3
2.0
4.2
3.34
0.8
0.55, 3.52
0.79, 3.75
0.06, 16.40
0.57, 2.95
0.82, 4.94
0.45, 39.23
1.49, 7.72
0.36, 1.71
Treatment-related factors
 Antibacterial therapy
 Antifungal therapy
 Central venous catheter
 Chemotherapy
 Hemodialysis 
 Hospital stay
 ICU stay
 Mechanical ventilation
 Organ transplant
 Steroid therapy
 Surgery
 Total parenteral nutrition
 Urinary catheter
53
20
50
16
15
52
31
33
5
16
22
25
47
32
1
38
13
7
37
18
19
3
4
11
6
26
0.000*
0.000*
0.003*
0.515
0.056
0.000*
0.012*
0.007*
0.452
0.003*
0.022*
0.000*
0.000*
36.4
31.1
5.2
1.3
2.6
11.9
2.7
2.9
1.7
5.2
2.7
6.9
7.2
4.68, 283.46
3.99, 243.15
1.62, 17.02
0.56, 3.12
0.95, 6.96
2.60, 54.87
1.23, 5.89
1.32, 6.32
0.39, 7.62
1.62, 17.02
1.14, 6.32
2.52, 18.80
2.77, 18.82
*denotes significant risk factors, p<0.05
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exposure followed by a prolonged hospital stay. Bivariate 
analysis identified several significant risk factors for 
candidaemia: Renal insufficiency, previous antibacterial 
therapy, previous antifungal therapy, central venous 
catheterization, prolonged hospital stay, prolonged ICU 
stay, use of mechanical ventilation, steroid therapy, surgery, 
total parenteral nutrition and urinary catheterization. 
However, after performing multivariate logistic regression 
analysis to remove the confounders, only five risk factors 
remained significant: one host-related factor i.e. renal 
insufficiency and four treatment-related factors i.e. 
previous antibacterial therapy, previous antifungal therapy, 
steroid therapy and urinary catheterization. Humoral and 
cell-mediated immunity are depressed in patients with 
acute renal failure thus candidaemia may become prevalent 
in patients with acute renal failure if they survive longer 
due to advances in intensive care and dialysis therapy 
(Sung et al. 2001). Confirming earlier reports (Bassetti et 
al. 2007; Blumberg et al. 2001; Bross et al. 1989; Sung 
et al. 2001; Wey et al. 1989), our study showed that renal 
insufficiency was independently related to candidaemia in 
the logistic regression model. 
 Our study did not find other significant host-related 
factors, which is in contrast to other studies that reported 
diabetes mellitus (Michalopoulos et al. 2003; Wu et al. 
2014), HIV infection (Chowta et al. 2007; Petrosillo et al. 
2002), malignancy (Zaoutis et al. 2010) and prematurity 
(Saiman et al. 2000; Wu et al. 2013), as significant risk 
factors. This could possibly due to several factors – our 
small sample size, particularly for HIV infection and 
prematurity; different study population by Zaoutis et 
al. (2010) who included only paediatric patients and 
diabetes mellitus being too prevalent in our population 
that it is present too often in both groups. As Candida is 
part of oropharyngeal flora, our study included cigarette 
smoking and alcohol intake as possible lifestyle factors 
for candidaemia. Studies have shown that exposure 
to cigarette smoke enhances the virulence of Candida 
albicans, which may lead to prolonged oral colonization 
(Baboni et al. 2009; Semlali et al. 2014). However, our 
study did not find any significant association between 
smoking and candidaemia. A recent study has shown that 
patients with severe alcoholic hepatitis are at an increased 
risk of developing invasive mycosis including candidaemia 
(Lahmer et al. 2014). Another study showed a higher 
incidence of Candida albicans and bacteria in the cultures 
of pharyngeal smears of alcoholics than the non-alcoholics 
(Fernández-Solá et al. 1995). However, our study did not 
show any significant association between alcohol intake 
and candidaemia. 
 Out of five significant independent risk factors for 
candidaemia identified, four were treatment-related factors, 
viz. antibacterial therapy, antifungal therapy, steroid 
therapy and urinary catheterization (Table 3). Antibacterial 
therapy, especially multiple agents, broad spectrum, 
high antianaerobic activity and high gastrointestinal 
concentration may preferentially suppress the normal 
bowel flora and lead to gastrointestinal colonization 
with Candida species (Akbar & Tahawi 2001; Bross et 
al. 1989; Cheng et al. 2006; Wey et al. 1989; Zaoutis et 
al. 2010). Meanwhile, patients who had prior antifungal 
therapy were found to be four times more likely to develop 
candidaemia (Table 2). However, it did not predict whether 
the causative organism was a non-albicans Candida 
(p=0.771; data not shown). A study by Feja et al. (2005) 
reported that prior antifungal therapy was a significant 
risk factor in the initial analysis but became insignificant 
after the multivariate analysis. Conversely, other studies 
found that prior antifungal therapy was a significant 
independent risk factor for developing candidaemia caused 
by non-albicans Candida (Almirante et al. 2006; Playford 
et al. 2008). Even though modern antifungal therapy has 
facilitated prophylaxis and treatment for invasive fungal 
infections in high risk patients, breakthrough candidaemia 
has been reported to be increasing (Pasqualotto et al. 2006). 
Therefore, antimicrobial stewardship program is strongly 
suggested to be put in place at healthcare institutions 
(Valerio et al. 2014). Corticosteroid therapy can depress 
humoral and cellular immunity, which are vital defence 
mechanisms for preventing deep tissue invasion by 
Candida (Sung et al. 2001). Our study showed that steroid 
therapy was an independent risk factor for candidaemia, 
TABLE 3. Multivariate logistic regression analysis of risk factors for candidaemia
Risk Factors Significant (p-value) Lower 95% CI Upper 95% CI
Antibacterial therapy
Antifungal therapy
Central venous catheter
Hospital stay
ICU stay
Mechanical ventilation
Renal insufficiency
Steroid therapy
Surgery
Total parenteral nutrition
Urinary catheter
0.030*
0.011*
0.251
0.191
0.604
0.769
0.016*
0.004*
0.693
0.130
0.006*
1.380
2.345
0.424
0.448
0.195
0.074
1.403
3.691
0.153
0.684
2.326
498.000
656.793
26.545
55.525
16.571
6.862
28.595
819.386
3.491
19.049
136.915
*denotes significant independent risk factors, p<0.05
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confirming a prior report by Han et al. (2010). In contrast, 
other studies found that steroid therapy was not associated 
with risk of developing candidaemia (Blumberg et al. 2001; 
Cheng et al. 2006). In fact, maternal steroid was found to 
be an independent protective factor against candidaemia 
in neonates (Linder et al. 2004). However, the exact 
mechanism is unclear. Urinary catheters and other invasive 
measures create numerous potential portals of entry for 
bacterial and mycotic pathogens. Our study showed that 
urinary catheter usage predisposed to candidaemia with a 
relative risk of 2.77 (Table 2), which is in line with findings 
by other studies (Bross et al. 1989; Saiman et al. 2000). 
Other studies reported that central venous catheterization 
(Bassetti et al. 2007; Petrosillo et al. 2002; Wu et al. 2013), 
prolonged hospital stay (Bassetti et al. 2007; Petrosillo 
et al. 2002), ICU stay (Amrutkar et al. 2006), mechanical 
ventilation (Saiman et al. 2000), surgery (Blumberg et 
al. 2001; Playford et al. 2008; Wu et al. 2013) and total 
parenteral nutrition (Amrutkar et al. 2006; Bassetti et al. 
2007; Blumberg et al. 2001) were significant risk factors 
for candidaemia. However, our study found that these 
risk factors were only significant in bivariate analysis but 
were insignificant after multivariate logistic regression 
analysis; indicating that although these factors were 
more commonly found among patients with candidaemia 
that those without, statistically they were not considered 
significant independent risk factors for candidaemia in our 
study.
 The authors acknowledge several limitations of 
the study. Firstly, this study was a retrospective study 
resulting in the exclusion of a few cases due to missing 
data and several biases may exist such as reporting bias 
and sampling bias. Hence, a prospective study is more 
preferable. Secondly, this study was a single-centred study; 
therefore the study population may not be representative 
of the actual population in other hospitals in the country. 
Small sample size in some categories of risk factors 
may influence accurate assessment of the risk factors 
for candidaemia. Thirdly, prognostic indicators such as 
inadequate initial therapy, source of candidaemia and 
susceptibility of the isolate to the antifungal drugs also 
were not evaluated in this study.
CONCLUSION
This study has identified five independent risk factors for 
candidaemia, which are prior antibacterial therapy, prior 
antifungal therapy, steroid therapy, urinary catheterization 
and renal insufficiency. Controlling, limiting or modifying 
these factors may reduce the incidence of candidaemia. 
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